Skip to main content

Table 1 Baseline characteristics of subjects according to the presence (MetS) or absence (controls) of metabolic syndrome.

From: Intracellular molecular effects of insulin resistance in patients with metabolic syndrome

  MetS (n = 40) Controls (n = 20) P
Sex (M/F) 32/8 14/6 NS
Age (years) 60 ± 3 58 ± 2 NS
BMI (Kg/m2) 30.1 ± 1.2 23.6 ± 0.8 P < 0.01
Blood pressure (mm Hg) 152/89 ± 2/1 129/79 ± 3/2 P < 0.01
Waist circumference 108 ± 5 82 ± 4 P < 0.01
Fasting glucose (mg/dl) 116 ± 7 87 ± 3 P < 0.01
OGTT (serum glucose after 120 min) (mg/dl) 187 ± 8 98 ± 4 P < 0.01
Serum cholesterol (mg/dl) 244 ± 5 186 ± 3 P < 0.01
Serum triglycerides (mg/dl) 207 ± 33 85 ± 20 P < 0.01
LDL cholesterol (mg/dl) 112 ± 7 100 ± 6 NS
HDL cholesterol (mg/dl) 47 ± 5 50 ± 3 NS
Serum creatinine 1.1 ± 0.1 0.9 ± 0.1 NS
Fasting insulin (μIU/mL) 12.0 ± 0.9 3.71 ± 0.4 P < 0.001
HOMA index 3.45 ± 2 0.8 ± 0.6 P < 0.01
  1. OGTT: oral glucose tolerance test
  2. HOMA index = Fasting insulin (μIU/mL)* fasting plasma glucose (FPG) (mmol/L)/22.5.